Literature DB >> 2942954

Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles.

B Swynghedauw.   

Abstract

The goal of this review is to summarize our knowledge of the plasticity of striated muscles in terms of contractile proteins. During development or when the working conditions are changed, the intrinsic physiological properties of both cardiac and skeletal muscles are modified. These modifications generally adapt the muscle to the new environmental requirements. One of the best examples is compensatory overload obtained in fast skeletal muscle by synergistic tenotomy and in a fast ventricle, such as in rats, by aortic banding. In both cases, after a few weeks the initial speed of shortening for the unloaded muscle drops, whereas the maximum tension developed remains unchanged. Heat measurements show that efficiency (i.e., g work/mol ATP) is improved at the fiber level. The fast skeletal muscle becomes slow, fatigue resistant, and then more adapted to endurance. For the ventricle as a whole to become slow is beneficial only if one contraction is considered; however, it is detrimental in terms of cardiac output and leads finally to failure. This adaptational process is partly explained by quantitative and qualitative changes in contractile proteins. Protein synthesis is rapidly enhanced and muscles hypertrophy, which in turn multiplies the contractile units and for the cardiac cylinder normalizes the wall stress. In the meantime the structure and, for myosin, the biological activity of several contractile proteins are modified. These modifications are very unlikely to be posttranscriptional and are in fact explained by several isoform shifts. In both tissues, for example, the expression of the gene coding for a fast myosin (MHCf in skeletal muscle, alpha-MHC in ventricles) is repressed and that of the gene coding for a slow myosin (beta-MHC in both tissues) is stimulated. This is accompanied by a coordinated increase in synthesis of other contractile proteins and, in skeletal muscle only, by isoform shifts of myosin light chains and of the TM-TN regulatory system. Other changes are less well understood. During development it has recently been discovered that three different MHCs (MHCemb, MHCneo, and MHCf) appear sequentially in fast skeletal muscle, which explains, for example, several contradictions of immunological cross-reactions. Currently, however, the functional significance of this finding is unknown, and the well-known decrease of shortening velocity observed in cardiac and skeletal muscles during fetal life is unexplained in terms of contractile proteins.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2942954     DOI: 10.1152/physrev.1986.66.3.710

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  141 in total

1.  The expression of the myogenic regulatory factors in denervated and normal muscles of different phenotypes.

Authors:  E H Walters; N C Stickland; P T Loughna
Journal:  J Muscle Res Cell Motil       Date:  2000       Impact factor: 2.698

2.  Protein kinase-A dependent phosphorylation of transcription enhancer factor-1 represses its DNA-binding activity but enhances its gene activation ability.

Authors:  M P Gupta; P Kogut; M Gupta
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

Review 3.  The molecular genetic basis for hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

4.  The gene expression fingerprint of human heart failure.

Authors:  Fen-Lai Tan; Christine S Moravec; Jianbo Li; Carolyn Apperson-Hansen; Patrick M McCarthy; James B Young; Meredith Bond
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

5.  Developmental changes in troponin T isoform expression and tension production in chicken single skeletal muscle fibres.

Authors:  P J Reiser; M L Greaser; R L Moss
Journal:  J Physiol       Date:  1992-04       Impact factor: 5.182

6.  Distribution of developmental myosin isoforms in isolated A-segments.

Authors:  D A Gordon; S Lowey
Journal:  J Muscle Res Cell Motil       Date:  1992-12       Impact factor: 2.698

7.  Myosin heavy-chain composition in striated muscle after tenotomy.

Authors:  A Jakubiec-Puka; C Catani; U Carraro
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

Review 8.  Hypertrophic cardiomyopathy: from genetics to treatment.

Authors:  Ali J Marian
Journal:  Eur J Clin Invest       Date:  2010-04       Impact factor: 4.686

9.  Remarkable heterogeneity in myosin heavy-chain composition of the human young masseter compared with young biceps brachii.

Authors:  Catharina Osterlund; Mona Lindström; Lars-Eric Thornell; Per-Olof Eriksson
Journal:  Histochem Cell Biol       Date:  2012-07-10       Impact factor: 4.304

10.  Loss of mXinalpha, an intercalated disk protein, results in cardiac hypertrophy and cardiomyopathy with conduction defects.

Authors:  Elisabeth A Gustafson-Wagner; Haley W Sinn; Yen-Lin Chen; Da-Zhi Wang; Rebecca S Reiter; Jenny L-C Lin; Baoli Yang; Roger A Williamson; Ju Chen; Cheng-I Lin; Jim J-C Lin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-08-31       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.